These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 9887245

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study.
    Ansquer Y, Leblanc E, Clough K, Morice P, Dauplat J, Mathevet P, Lhommé C, Scherer C, Tigaud JD, Benchaib M, Fourme E, Castaigne D, Querleu D, Dargent D.
    Cancer; 2001 Jun 15; 91(12):2329-34. PubMed ID: 11413522
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.
    Vergote I, Amant F, Kristensen G, Ehlen T, Reed NS, Casado A.
    Eur J Cancer; 2011 Sep 15; 47 Suppl 3():S88-92. PubMed ID: 21944035
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
    Colombo PE, Mourregot A, Fabbro M, Gutowski M, Saint-Aubert B, Quenet F, Gourgou S, Rouanet P.
    Eur J Surg Oncol; 2009 Feb 15; 35(2):135-43. PubMed ID: 18289825
    [Abstract] [Full Text] [Related]

  • 8. The position of neoadjuvant chemotherapy within the treatment of ovarian cancer.
    Van Gorp T, Amant F, Neven P, Berteloot P, Leunen K, Vergote I.
    Minerva Ginecol; 2006 Oct 15; 58(5):393-403. PubMed ID: 17006426
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neoadjuvant chemotherapy for advanced ovarian cancer.
    Schwartz PE, Chambers JT, Makuch R.
    Gynecol Oncol; 1994 Apr 15; 53(1):33-7. PubMed ID: 8175019
    [Abstract] [Full Text] [Related]

  • 13. Neoadjuvant intraarterial chemotherapy and embolization in treatment of advanced ovarian epithelial carcinoma.
    Liu EL, Mi RR.
    Chin Med J (Engl); 2004 Oct 15; 117(10):1547-51. PubMed ID: 15498381
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Neoadjuvant chemotherapy and ovarian cancer].
    Ray-Coquard I, Saba C, Bachelot T, Méeus P, Mignotte H, Blondet R, Treilleux I, Peix M, Guastalla JP.
    Bull Cancer; 2006 Jul 15; 93(7):669-76. PubMed ID: 16873075
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of postoperative morbidities in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy and delayed primary surgical debulking.
    Le T, Alshaikh G, Hopkins L, Faught W, Fung MF.
    Ann Surg Oncol; 2006 Dec 15; 13(12):1711-6. PubMed ID: 17009146
    [Abstract] [Full Text] [Related]

  • 17. Neoadjuvant chemotherapy in ovarian cancer.
    Park TW, Kuhn WC.
    Expert Rev Anticancer Ther; 2004 Aug 15; 4(4):639-47. PubMed ID: 15270667
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer.
    Munkarah AR, Hallum AV, Morris M, Burke TW, Levenback C, Atkinson EN, Wharton JT, Gershenson DM.
    Gynecol Oncol; 1997 Jan 15; 64(1):13-7. PubMed ID: 8995541
    [Abstract] [Full Text] [Related]

  • 20. Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer.
    Morice P, Dubernard G, Rey A, Atallah D, Pautier P, Pomel C, Lhommé C, Duvillard P, Castaigne D.
    J Am Coll Surg; 2003 Dec 15; 197(6):955-63. PubMed ID: 14644284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.